Effect of the consumption of a fermented dairy product containing Bifidobacterium lactis DN-173 010 on constipation in childhood: A multicentre randomised controlled trial (NTRTC: 1571)

BMC Pediatrics

Volumn 9, Issue 1, 2009, Pages

  Tabbers, Merit M ^a   Chmielewska, Ania ^b   Roseboom, Maaike G ^a   Boudet, Claire ^c   Perrin, Catherine ^c   Szajewska, Hania ^b   Benninga, Marc A ^a  

^a EMMA CHILDREN S HOSPITAL   (Netherlands)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

^c ALTRAN TECHNOLOGIES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIA; BISACODYL; PLACEBO; PROBIOTIC AGENT; UNCLASSIFIED DRUG; YOGHURT;

ABDOMINAL PAIN; ADOLESCENT; ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIUM ANIMALIS; CHILD; CHILD HEALTH; CLINICAL TRIAL; CONSTIPATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DAIRY PRODUCT; DEFECATION; DIARRHEA; DOUBLE BLIND PROCEDURE; FECES ANALYSIS; FEMALE; FERMENTED PRODUCT; FLATULENCE; FOOD INTAKE; HUMAN; MAJOR CLINICAL STUDY; MALE; MILK; MULTICENTER STUDY; NAUSEA; NETHERLANDS; POLAND; TASTE DISORDER; TREATMENT DURATION; TREATMENT RESPONSE; BIFIDOBACTERIUM; ETHNOLOGY; MICROBIOLOGY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADOLESCENT; BIFIDOBACTERIUM; CHILD; CHILD, PRESCHOOL; CONSTIPATION; DAIRY PRODUCTS; DEFECATION; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; NETHERLANDS; POLAND; TREATMENT OUTCOME; YOGURT;

EID: 63849274169     PISSN: None     EISSN: 14712431     Source Type: Journal    
DOI: 10.1186/1471-2431-9-22     Document Type: Article

References (18)

1. Berg van den MM Benninga MA Di LC Epidemiology of childhood constipation: A systematic review Am J Gastroenterol 2006, 101(10):2401-9 10.1111/j.1572-0241.2006.00771.x 17032205
2. Benninga MA Voskuijl WP Taminiau JA Childhood constipation: Is there new light in the tunnel? J Pediatr Gastroenterol Nutr 2004, 39(5):448-64 10.1097/00005176-200411000-00002 15572881
3. Berg van den MM van Rossum CH de LF Reitsma JB Di LC Benninga MA Functional constipation in infants: A follow-up study J Pediatr 2005, 147(5):700-4 10.1016/j.jpeds.2005.05.032 16291368
4. Pijpers MA Tabbers MM Benninga MA Berger MY Currently recommended treatments of childhood constipation are not evidence based: A systematic literature review on the effect of laxative treatment and dietary measures Arch Dis Child 2009, 94(2):117-31 10.1136/ adc.2007.127233 18713795
5. Voskuijl W de LF Verwijs W Hogeman P Heijmans J Makel W et al PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: A double blind, randomised, controlled, multicentre trial Gut 2004, 53(11):1590-4 1774276 15479678 10.1136/gut.2004.043620
6. Gill HS Guarner F Probiotics and human health: A clinical perspective Postgrad Med J 2004, 80(947):516-26 1743098 15356352 10.1136/ pgmj.2003.008664
7. Picard C Fioramonti J Francois A Robinson T Neant F Matuchansky C Review article: Bifidobacteria as probiotic agents - physiological effects and clinical benefits Aliment Pharmacol Ther 2005, 22(6):495-512 10.1111/ j.1365-2036.2005.02615.x 16167966
8. Szajewska H Setty M Mrukowicz J Guandalini S Probiotics in gastrointestinal diseases in children: Hard and not-so-hard evidence of efficacy J Pediatr Gastroenterol Nutr 2006, 42(5):454-75 10.1097/ 01.mpg.0000221913.88511.72 16707966
9. Marteau P Cuillerier E Meance S Gerhardt MF Myara A Bouvier M et al Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: A double-blind, randomized, controlled study Aliment Pharmacol Ther 2002, 16(3):587-93 10.1046/ j.1365-2036.2002.01188.x 11876714
10. Bouhnik Y Raskine L Simoneau G Vicaut E Neut C Flourie B et al The capacity of nondigestible carbohydrates to stimulate fecal bifidobacteria in healthy humans: A double-blind, randomized, placebo-controlled, parallel-group, dose-response relation study Am J Clin Nutr 2004, 80(6):1658-64 15585783
11. Meance S Cayuela C Turchet P A fermented milk with a Bifidobacterium probiotic Strain DN-173 010 shortened oro-fecal gut transit time in elderly Microb Ecol Health Dis 2001, 13:217-27 10.1080/089106001753341291
12. Meance S Cayuela C Raimondi A Recent advances in the use of functional foods: Effects of the commercial Fermented Milk with Bifidobacterium Animalis Strain DN-173 010 and Yoghurt strains on gut transit time in the elderly Microb Ecol Health Dis 2003, 15:15-22 10.1080/ 08910600310015565
13. Nishida S Ushikawa Y Iino H Effect of Bifidobacterium lactis DN-173010 on the intestinal transit time, the condition of defecation and intestinal microflora: A randomized, double-blind, placebo-controlled, cross-over study among healthy Japanese women Pharmacometrics (Oyo Yakuri) 2008, 74(5/6):99-106
14. Agrawal A Houghton LA Morris J Reilly B Guyonnet D Goupil FN et al Clinical trial: The effects of a fermented milk product containing Bifidobacterium lactis DN-173-010 on abdominal distension and gastrointestinal transit in irritable bowel syndrome with constipation Aliment Pharmacol Ther 2008
15. Guyonnet D Chassany O Ducrotte P Picard C Mouret M Mercier CH et al Effect of a fermented milk containing Bifidobacterium animalis DN-173 010 on the health-related quality of life and symptoms in irritable bowel syndrome in adults in primary care: A multicentre, randomized, double-blind, controlled trial Aliment Pharmacol Ther 2007, 26(3):475-86 17635382
16. Yang YX He M Hu G Wei J Pages P Yang XH et al Effect of a fermented milk containing Bifidobacterium lactis DN-173010 on Chinese constipated women World J Gastroenterol 2008, 14(40):6237-43 10.3748/wjg.14.6237 18985817
17. Rasquin A Di LC Forbes D Guiraldes E Hyams JS Staiano A et al Childhood functional gastrointestinal disorders: Child/adolescent Gastroenterology 2006, 130(5):1527-37 10.1053/j.gastro.2005.08.063 16678566
18. Plas van der RN Benninga MA Redekop WK Taminiau JA Buller HA How accurate is the recall of bowel habits in children with defaecation disorders? Eur J Pediatr 1997, 156(3):178-81 10.1007/s004310050577 9083754